Skip to main content
Account

Peer review reports

From: Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience

Original Submission
9 Oct 2011 Submitted Original manuscript
31 Oct 2011 Reviewed Reviewer Report - Matthew Resnick
1 Dec 2011 Reviewed Reviewer Report - Alicia Morgans
14 Jan 2012 Author responded Author comments - Kazuhiko Nakano
Resubmission - Version 2
14 Jan 2012 Submitted Manuscript version 2
Publishing
22 Feb 2012 Editorially accepted
22 Feb 2012 Article published 10.1186/1471-2490-12-3

Learn about peer review

Back to article page

Navigation